Browsing Over 63 Sessions

Sort By
7.3.S - Strasbourg Auditorium EONS Industry Satellite Symposium

AstraZeneca, Eli Lilly, Novartis - Experience of living with Early Breast Cancer, treatment and beyond: What are we missing

Date
Sat, 10.09.2022
Time
12:00 - 13:30
Room
7.3.S - Strasbourg Auditorium

Pfizer Oncology - Journey through patient care: Long-term experience in advanced breast cancer (ID 99)

Time
13:00 - 14:30

Merck Pfizer Alliance - New approaches to optimize treatment outcomes in advanced urothelial carcinoma (ID 104)

Time
13:00 - 14:30

GSK - Avant-garde: Reframing the art of first-line maintenance therapy to optimise long-term outcomes in advanced ovarian cancer (ID 101)

Time
13:00 - 14:30

Incyte Biosciences International Sàrl  - Targeting FGFR alterations in cholangiocarcinoma and other solid tumours: A new frontier in personalised medicine (ID 97)

Time
13:00 - 14:30

Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients (ID 102)

Time
13:00 - 14:30

MSD - Navigating through the rapidly evolving treatment landscape for GI Cancers - A Clinical & Patient Centric Approach towards implementing Immunotherapy (ID 98)

Time
13:00 - 14:29

Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers (ID 103)

Time
13:00 - 14:30
7.3.S - Strasbourg Auditorium EONS Industry Satellite Symposium

Bristol Myers Squibb - Cancer Nursing Considerations for comprehensive care in CAR T-Cell Therapy

Date
Sat, 10.09.2022
Time
15:00 - 16:30
Room
7.3.S - Strasbourg Auditorium

PeerVoice - Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC (ID 108)

Time
18:30 - 19:55

Medscape Oncology Global - Improving Outcomes in Patients With High-Risk HR+/HER2- EBC: Keeping the Patient Central (ID 112)

Time
18:30 - 20:00

Janssen-Cilag International NV - Exploring questions in metastatic prostate cancer (ID 105)

Time
18:30 - 20:00